1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

PACE team response shows a disregard for the principles of science, 2017, Edwards

Discussion in 'Psychosomatic research - ME/CFS and Long Covid' started by MSEsperanza, Feb 20, 2022.

  1. MSEsperanza

    MSEsperanza Senior Member (Voting Rights)

    Messages:
    2,857
    Location:
    betwixt and between
    Edwards J. PACE team response shows a disregard for the principles of science. Journal of Health Psychology. 2017;22(9):1155-1158. doi:10.1177/1359105317700886

    Abstract

    The PACE trial of cognitive behavioural therapy and graded exercise therapy for chronic fatigue syndrome/myalgic encephalomyelitis has raised serious questions about research methodology.

    An editorial article by Geraghty gives a fair account of the problems involved, if anything understating the case. The response by White et al. fails to address the key design flaw, of an unblinded study with subjective outcome measures, apparently demonstrating a lack of understanding of basic trial design requirements.

    The failure of the academic community to recognise the weakness of trials of this type suggests that a major overhaul of quality control is needed.

    (This is a commnentary on: White PD, Chalder T, Sharpe M, et al. Response to the editorial by Dr Geraghty. Journal of Health Psychology. 2017;22(9):1113-1117. doi:10.1177/1359105316688953 )
     
    Last edited: Feb 20, 2022
  2. MSEsperanza

    MSEsperanza Senior Member (Voting Rights)

    Messages:
    2,857
    Location:
    betwixt and between

    See also: Tuller D. Once again, the PACE authors respond to concerns with empty answers. Journal of Health Psychology. 2017;22(9):1118-1122. doi:10.1177/1359105317703788

    Thread here.
     
    Last edited: Feb 20, 2022

Share This Page